Sansure Biotech Inc. (688289.SS)

CNY 22.2

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.45 Billion 9.17 Billion 7.09 Billion 5.45 Billion 642.46 Million 552.04 Million
Total Current Assets 5.94 Billion 7.52 Billion 5.96 Billion 5.08 Billion 437.2 Million 359.11 Million
Cash And Short Term Investments 4.78 Billion 5.66 Billion 4.68 Billion 4.19 Billion 165.49 Million 127.01 Million
Cash and Cash Equivalents 4.23 Billion 3.21 Billion 2.63 Billion 2.59 Billion 99.16 Million 127.01 Million
Short Term Investments 548.27 Million 2.45 Billion 2.04 Billion 1.6 Billion 66.32 Million -
Net Receivables 732.75 Million 1.47 Billion 894.07 Million 606.69 Million 195.59 Million 171.06 Million
Inventory 376.63 Million 355.31 Million 369.5 Million 276.73 Million 64.66 Million 55.89 Million
Other Current Assets 58.44 Million 33.59 Million 19.96 Million 7.24 Million 11.45 Million 5.13 Million
Total Non-Current Assets 2.5 Billion 1.64 Billion 1.12 Billion 371.66 Million 205.26 Million 192.93 Million
Net PPE 1.05 Billion 785.26 Million 481.02 Million 216.54 Million 176.5 Million 162.69 Million
Good Will And Intangible Assets 335.62 Million 84.44 Million 45.55 Million 31.23 Million 11.49 Million 11.23 Million
Good Will 7.66 Million - - - - -
Intangible Assets 327.96 Million 84.44 Million 45.55 Million 31.23 Million 11.49 Million 11.23 Million
Long-Term Investments 974.33 Million -1.79 Billion -1.53 Billion -1.49 Billion 4.76 Million 3.41 Million
Tax Assets 73.82 Million 69.61 Million 24.99 Million 17.22 Million 11.46 Million 11.93 Million
Other Non Current Assets 65.6 Million 2.5 Billion 2.1 Billion 1.6 Billion 1.02 Million 3.64 Million
Other Assets 1.00 - 1.00 - 1.00 -
Total Liabilities 996.81 Million 1.66 Billion 709.02 Million 708.94 Million 84.98 Million 155.75 Million
Total Current Liabilities 919.15 Million 1.57 Billion 663.93 Million 688.68 Million 73.36 Million 145.17 Million
Account Payables 468.65 Million 791.41 Million 258.7 Million 272.26 Million 35.26 Million 42.55 Million
Tax Payables 17.65 Million 216.35 Million 101.31 Million 112.06 Million 4.65 Million 3.96 Million
Short Term Debt 77.23 Million 14.25 Million 8.48 Million 55 Million -6.61 Million -5.31 Million
Deferred Revenue 32.8 Million 53.1 Million 394.35 Million 358.09 Million 6.61 Million 5.31 Million
Other Current Liabilities 340.46 Million 712.94 Million 2.39 Million 3.32 Million 38.09 Million 102.62 Million
Total Non Current Liabilities 77.65 Million 89.26 Million 45.09 Million 20.26 Million 11.62 Million 10.57 Million
Long-Term Debt 18.21 Million 13.59 Million 6.4 Million 3.18 Million - -
Deferred Revenue Non Current 32.48 Million 30.53 Million 25.67 Million 18.95 Million 11.42 Million 10.57 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -32.48 Million 26.09 Million - -3.18 Million - -
Other Liabilities 1.00 1.00 1.00 - - 1.00
Total Equity 7.42 Billion 7.51 Billion 6.38 Billion 4.74 Billion 557.47 Million 396.28 Million
Stock Holders Equity 7.2 Billion 7.5 Billion 6.36 Billion 4.74 Billion 557.47 Million 396.28 Million
Common Stock 588.45 Million 588.45 Million 400 Million 400 Million 360 Million 127.86 Million
Retained Earnings 4.88 Billion 5.07 Billion 3.82 Billion 2.02 Billion -28.23 Million -300.38 Million
Accumulated other comprehensive income 395.21 Million 377.42 Million 293.95 Million 263.84 Million 34.2 Thousand 568.81 Million
Common Stock Equity 7.2 Billion 7.5 Billion 6.36 Billion 4.74 Billion 557.47 Million 396.28 Million
Capital Lease Obligation 18.21 Million 13.59 Million 6.4 Million 3.18 Million - -
Total Investments 1.52 Billion 657.43 Million 513.22 Million 102.5 Million 66.32 Million 3.41 Million
Total Debt 95.44 Million 27.85 Million 14.89 Million 55 Million - -
Net Debt -4.13 Billion -3.18 Billion -2.62 Billion -2.53 Billion -99.16 Million -127.01 Million

Balance Sheet Charts